Find disease awareness content and relevant supporting materials

Latest data and clinical guidance

The cardiovascular metabolism (CVM) Learning Zone hosted on Medthority.com features over 70 expert opinion videos covering type 2 diabetes and hypertension.

These Japanese guidelines present IRD‑specific specifications to the ACMG/AMP framework for genetic variant interpretation. By incorporating population‑specific disease frequencies and phenotypic features, they aim to improve the accuracy and consistency of inherited retinal dystrophy diagnosis in Japan.

These Italian Society of Rheumatology guidelines provide evidence‑based recommendations for managing patients with rheumatoid arthritis and interstitial lung disease. They address RA drug safety in ILD, ILD‑specific therapies, and treatment strategies following first‑line failure.

These joint Portuguese guidelines provide clinical practice recommendations for genetic testing in inherited retinal dystrophies, emphasising the central role of molecular diagnosis. They address testing indications, counselling requirements, variant interpretation, cascade testing, and follow‑up to improve patient care and outcomes.

Guideline updates on multiple myeloma management

The European Association of Urology (EAU) Urological Infections Guidelines Panel has compiled these clinical guidelines to provide medical professionals with evidence-based information and recommendations for...

The EAU PCa Guidelines were first published in 2001. Standard procedure for EAU Guidelines includes an annual assessment of newly published literature in the field to guide future updates. This 2025 PCa Guidelines present a limited update of the 2024 publication.

The European Association of Urology (EAU) presents updated guidelines on the evidence-based management of urolithiasis. These recommendations address urinary tract stone treatment, including bladder stones, and consider geographic variations in care delivery.

Read about, and access, the current guidelines for the management of psoriasis developed by the AAD, EADV, the British Association of Dermatologists and more.